…for our monthly email newsletter and other communications. Page sources Anixa Biosciences Announces Treatment of First Patient in its Ovarian Cancer CAR-T Clinical Trial. Biospace. Retrieved from: https://www.biospace.com/article/releases/anixa-biosciences-announces-treatment-of-first-patient-in-its-ovarian-cancer-car-t-clinical-trial/. Accessed: 09/09/2022….
…up for our monthly newsletter. Page sources BioNTech Presents Encouraging Phase 1/2 Follow-up Data for CAR-T Candidate BNT211 in Hard-To-Treat Solid Tumors at ESMO. Yahoo. Retrieved from: https://www.yahoo.com/now/biontech-presents-encouraging-phase-1-143000094.html. Accessed: 09/12/2022….
https://www.youtube.com/watch?v=mMGsaw0W0lE…
https://www.youtube.com/watch?v=9-KNerTWgRs&authuser=0 With guidance from our Scientific Advisory Council and Board of Directors, the organization considers funding projects with robust scientific foundations and clearly defined paths to the clinic and the…
https://www.youtube.com/watch?v=lIumUed7ZPI With success in overcoming blood cancers established, our current funding priorities focus on new curative strategies for the most difficult-to-treat solid tumor cancers – glioblastoma, a brain cancer, and…
…Cancer Immunotherapy, Sloan Kettering Institute Scientists Say. Memorial Sloan Kettering Cancer Center. Retrieved from: https://www.mskcc.org/news/discovery-stem-cell-type-1-diabetes-holds-potential-improving-cancer-immunotherapy-sloan-kettering-institute-scientists-say. Accessed: 12/6/2021. Survival Rates for Pancreatic Cancer. American Cancer Society. Retrieved from: https://www.cancer.org/cancer/pancreatic-cancer/detection-diagnosis-staging/survival-rates.html. Accessed: 01/04/2021….
…Cancer Research Institute. Retrieved from: https://www.cancerresearch.org/en-us/immunotherapy/treatment-types/immunomodulators-checkpoint-inhibitors. Accessed: 03/18/2022. Side Effects of Immunotherapy. American Society of Clinical Oncology. Retrieved from: https://www.cancer.net/navigating-cancer-care/how-cancer-treated/immunotherapy-and-vaccines/side-effects-immunotherapy. Accessed: 03/22/2022. PTP1B Is an Intracellular Checkpoint that Limits T-cell…
…on the ACGT website. Page sources Key Statistics for Pancreatic Cancer. American Cancer Society. Retrieved from: https://www.cancer.org/cancer/types/pancreatic-cancer/about/key-statistics.html. Accessed: 09/29/2023. Pancreatic Cancer Prognosis. Johns Hopkins Medicine. Retrieved from: https://www.hopkinsmedicine.org/health/conditions-and-diseases/pancreatic-cancer/pancreatic-cancer-prognosis. Accessed: 09/29/2023….
…6 things to know. National Cancer Institute. Retrieved from: https://www.cancer.gov/news-events/cancer-currents-blog/2024/fda-amtagvi-til-therapy-melanoma. Accessed: 03/15/2024. Breakthrough Treatment for Solid Tumors With TIL Therapy. University of Maryland Medical Center. Retrieved from: https://www.umms.org/ummc/pros/physician-briefs/cancer/immunotherapy/til-therapy. Accessed: 03/15/2024….
…cancer – and the first for a solid tumor. Phase 3 clinical trial leads to approval The FDA approval comes on the heels of a Phase 3 trial using KIMMTRAK…
…T cells. HLA is part of the major histocompatibility complex (MHC), which includes fragments of proteins called peptides. When these peptides are from a cancerous protein, HLA presents them to…
…(BCH), ChainLink (LINK), Compound (COMP), Curve (CRV), Dai (DAI), Decentraland (MANA), Dogecoin (DOGE), Enjin Coin (ENJ), Fantom (FTM), Filecoin (FIL), Gemini Dollar (GUSD), Injective Protocol (INJ), Kyber Network (KNC), Litecoin…
…can try the cell and gene therapy. Another type of T-cell therapy is engineered T-cell receptors. These enhanced T cells look for proteins broken down in the major histocompatibility complex,…
…receiving Breyanzi. In a recent phase 2 clinical trial, 45% of CLL and SLL patients had an anti-tumor response after receiving Breyanzi and 18.4% had a complete response (no sign…
…dedicated to improving cancer patient outcomes by advancing the science and application of cancer immunotherapy through educational programs that foster scientific exchange and collaboration. Learn more about SITC at www.sitcancer.org….
…Cancer Gene Therapy funding, continues to be life-changing and life-saving for many people. As the focus shifts to solid tumors, Dr. June is again leading the medical community forward to…
…2003. “Since the day it was founded, ACGT has been committed to achieving a better understanding of cancer biology and immunology, translating that understanding into game-changing clinical therapies,” says Dr….
…around commercial CAR T-cell dosing and didn’t know if higher doses would affect toxicity and compromise outcomes, or support enhanced anti-leukemia effect. This data has direct clinical applicability, as it…
Alliance for Cancer Gene Therapy (ACGT) is committed to advancing the science of cancer cell and gene therapy to transform cancer treatment and improve the outcome for patients. This commitment…
…cells’ specific characteristics – such as protein antigens serving as fingerprint identification – are crucial. These cells react quickly and with force when they come into contact with other cancer…
